

Most Read This Week
- Alpelisib Plus Fulvestrant in PIK3CA-Mutated, HR+ Advanced Breast Cancer After a CDK4/6 Inhibitor
- Patient-Reported Outcomes of PIK3CA-Mutated HR+, HER2− Advanced Breast Cancer
- Palbociclib and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy
- Improved Survival Among Patients With Bone-Only Metastatic Breast Cancer
- Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Studies
Recently Updated
- Validation and Comparison of B-GPA Scores in Patients With Breast Cancer and Brain Metastases
- Patient-Reported Outcomes of PIK3CA-Mutated HR+, HER2− Advanced Breast Cancer
- Alpelisib Plus Fulvestrant in PIK3CA-Mutated, HR+ Advanced Breast Cancer After a CDK4/6 Inhibitor
- HER2-Positive Result After Neoadjuvant Chemo
- Improved Survival Among Patients With Bone-Only Metastatic Breast Cancer